Health
Death probe of ex-Yankee's son triggers carbon monoxide warnings from experts

Experts are speaking out about the potential dangers attached to carbon monoxide, as authorities continue to probe the death of teen Miller Gardner, son of former New York Yankees player Brett Gardner.
While the cause of Miller Gardner’s death remains unconfirmed, Costa Rican Judicial Investigative Agency (OIJ) General Director Randall Zúñiga told reporters at a press conference on Monday that high levels of carbon monoxide contamination were found in the Gardner family’s hotel room, and that it might have caused the teen’s death.
“Which then leads us towards a line of investigation in which it seems that this person could have died from inhaling these very dangerous gases,” Zúñiga said.
Zúñiga said investigators who work on a specialized dangerous atmospheres team detected “high emissions of pollution of…carbon monoxide” in the room at Costa Rica’s Arenas Del Mar Beachfront & Rainforest Resort, which is where the Gardners were staying.
Officials at the hotel are denying the carbon monoxide claims.
DEATH OF EX-YANKEE’S SON IN COSTA RICA HAS EXPERTS SOUNDING ALARM ON HEALTHY TRAVEL
“The levels in the hotel room were non-existent and non-lethal. There was an error in this initial reporting. As mentioned, we await for conclusive results to confirm the cause of this unfortunate death,” a hotel spokesperson told Fox News Digital.
The spokesperson also said the room has been “closed off out of an abundance of precaution.”
Miller Gardner, 14, is photographed with his father, Brett Gardner, a former New York Yankee. Miller Gardner died last month in Costa Rica. His death is currently being investigated. (Courtesy of New York Yankees)
Dr. Nicole Saphier, a Fox News medical contributor, said no parent should ever have to endure the tragedy of losing a child.
In regard to carbon monoxide, she said the gas is “a silent, deadly threat.”
“We often focus on smoke alarms, but carbon monoxide is colorless, odorless and can overcome a person before they even realize what’s happening,” Saphier told Fox News Digital.
Saphier said every household should have multiple functioning carbon monoxide detectors, especially near sleeping areas.
For more Health articles, visit www.foxnews.com/health
“When we travel — whether staying at a hotel, Airbnb, or even in an RV — it’s worth considering bringing a portable carbon monoxide monitor for added protection,” she suggested.

The death of Miller Gardner, son of former New York Yankee Brett Gardner, has experts speaking out about carbon monoxide after the teen died while on vacation in Costa Rica. (AP Photo/Seth Wenig)
Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and a Fox News senior medical analyst, said, “symptoms can come on rapidly within minutes or hours and can include headache, nausea, fatigue, dizziness and vomiting.”
If you experience symptoms that you think could be from carbon monoxide poisoning, the Environmental Protection Agency recommends opening doors and windows, turning off combustion appliances and leaving the building.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Siegel said prompt treatment with oxygen can sometimes reverse carbon monoxide poisoning.

Between 2009 and 2019, deaths from non-fire-related carbon monoxide poisoning have been on the rise, according to a new report released by the CPSC. (iStock)
“It is absolutely shocking to me that it took this long to be disclosed as a likely cause of death, when they could have done a test for carbon monoxide in [Miller Gardener’s] blood within hours during his autopsy weeks ago,” Siegel told Fox News Digital.
Between 2009 and 2019, deaths from non-fire-related carbon monoxide poisoning were on the rise, according to a report released by the U.S. Consumer Product Safety Commission (CPSC) in March 2023.
Fox News Digital reached out to OIJ in Costa Rica for additional comment.

Health
Lose Weight While Dining Out: Tips That Helped Readers Drop Up to 119 Lbs

Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

Injectables for type 2 diabetes and weight loss could soon be a thing of the past.
Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill.
The ACHIEVE-1 trial evaluated the efficacy of Orforglipron compared to placebo in adults with type 2 diabetes and “inadequate glycemic control with diet and exercise alone.”
FAKE OZEMPIC DRUGS FOUND IN US DRUG SUPPLY, FDA WARNS
The results showed lowered A1C (blood sugar) in patients by an average of 1.3% to 1.6% across doses, according to a press release.
Orforglipron is a once-daily oral pill for diabetes and weight loss. (iStock)
More than 65% of participants taking the highest dose of the drug scored an A1C less than or equal to 6.5%, which is below the defined threshold for diabetes, according to the American Diabetes Association.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Trial participants also saw reduced weight by an average of 16 pounds, or 7.9%, at the highest dose.
Participants had not reached a weight plateau when the study ended, which suggests there was still weight to be lost, according to the researchers.

The experimental drug is made by Eli Lilly, the Indiana-based pharmaceutical company that also makes Mounjaro and Zepbound. (iStock)
The trial also found that the overall safety and tolerability of the drug was consistent with the classic injectable GLP-1s, like Ozempic, Wegovy, Mounjaro and Zepbound.
If Orforglipron achieves approval by the U.S. Food and Drug Administration, Eli Lilly projected its confidence in launching the drug “worldwide without supply constraints.”
For more Health articles, visit www.foxnews.com/health
“This would further Lilly’s mission to reduce chronic diseases like type 2 diabetes, which is expected to impact an estimated 760 million adults by 2050,” the pharmaceutical company wrote in its announcement.

The trial found that the overall safety and tolerability of the drug was consistent with other injectable GLP-1s. (iStock)
David A. Ricks, Eli Lilly chair and CEO, commented in a statement, “We are pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control and weight loss, and we look forward to additional data readouts later this year.”
“As a convenient once-daily pill, Orforglipron may provide a new option and, if approved, could be readily manufactured and launched at scale for use by people around the world.”
Eli Lilly intends to submit Orforglipron for weight management to global regulatory agencies by the end of 2025, as well as for type 2 diabetes treatment in 2026, according to the company.
Health
Here’s Why You’re Gaining Weight and How to Shed Those Pounds

Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
-
Movie Reviews1 week ago
Film Review: 'Warfare' is an Immersive and Intense Combat Experience – Awards Radar
-
News1 week ago
3 Are Killed in Shooting Near Fredericksburg, Va., Authorities Say
-
Health1 week ago
As RFK Jr. Champions Chronic Disease Prevention, Key Research Is Cut
-
News1 week ago
Boris Johnson Has Run-In With Feisty Ostrich During Texas Trip
-
World1 week ago
EPP boss Weber fells 'privileged' to be targeted by billboard campaign
-
Technology1 week ago
Meta got caught gaming AI benchmarks
-
World1 week ago
DR Congo repatriates three US citizens convicted over failed coup
-
News1 week ago
Trump Asks Supreme Court to Let Him Fire Agencies’ Leaders